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Detection of low-affinity or transient interactions can be a
bottleneck in our understanding of signaling networks. To
address this problem, we developed an arrayed screening
strategy based on protein complementation to systemat-
ically investigate protein-protein interactions in live hu-
man cells, and performed a large-scale screen for regu-
lators of telomeres. Maintenance of vertebrate telomeres
requires the concerted action of members of the Te-
lomere Interactome, built upon the six core telomeric pro-
teins TRF1, TRF2, RAP1, TIN2, TPP1, and POT1. Of the
12,000 human proteins examined, we identified over 300
proteins that associated with the six core telomeric pro-
teins. The majority of the identified proteins have not been
previously linked to telomere biology, including regulators
of post-translational modifications such as protein ki-
nases and ubiquitin E3 ligases. Results from this study
shed light on the molecular niche that is fundamental to
telomere regulation in humans, and provide a valuable
tool to investigate signaling pathways in mammalian
cells. Molecular & Cellular Proteomics 10: 10.1074/mcp.
M110.001628, 1–11, 2011.
During mammalian DNA replication, linear chromosomal
ends will gradually erode because of the inability of the DNA
replication machinery to replicate the extreme 5 terminus of a
linear DNA sequence (1, 2). This inherent “end replication
problem” is circumvented through specialized chromosomal
end structures (telomeres) and the action of the RNA-contain-
ing DNA polymerase - telomerase (3–9). Telomere homeosta-
sis is essential for genome stability, cell survival, and growth.
Telomeres and telomerase help to ensure genome integrity in
eukaryotes by enabling complete replication of the ends of
linear DNA molecules, and preventing chromosomal rear-
rangements or fusion. For dividing cells such as stem cells
and the majority of cancer cells, the telomerase is an essential
positive regulator of their telomere length and ultimately de-
termines the proliferative potential of these cells.
Mammalian telomeres consist of a series of (TTAGGG)n
sequence repeats and terminate in 3 single-stranded DNA
overhangs that are extendable by the telomerase (10). Ex-
posed linear chromosome ends or naturally occurring double-
stranded breaks pose additional risks including activation of
DNA damage responses. The ends of telomeres in mamma-
lian cells appear to fold back in a T-loop structure, with the 3
G-rich single-stranded overhang invading into the double-
stranded telomere regions to form the D-loop (11). The struc-
ture of the telomeres, coupled with the coordinated action of
a collection of proteins that protect the ends of chromosomes
(12–15), contributes to the maintenance of telomere integrity,
genome stability, and proper cell cycle progression.
In mammals, the most widely studied telomere-associated
proteins include the double-stranded DNA binding proteins
TRF1 and TRF2 (16, 17), the single-stranded telomeric DNA
binding protein POT1 (18), and three associated factors
(RAP1, TIN2, and TPP1) (19–23). Work from our lab and
others suggest that TPP1, along with POT1, TIN2, TRF1,
TRF2, and RAP1, form a higher order complex (the telosome/
shelterin) at the telomeres (24–27). Information regarding the
state of the telomere ends can be transmitted from TRF1 and
TRF2 to POT1, through TPP1 and the other subunits (28).
Furthermore, TRF1 and TRF2 function as bona fide protein
hubs and interact with a diverse array of factors/complexes
that are involved in cell cycle, DNA repair, and recombination
to maintain telomere structure and length (12, 13, 27, 29–34).
Consistent with the end protection function of this complex,
many factors that are known to participate in DNA damage
responses are recruited to the telomeres, such as the Mre11/
Rad50/NBS1 complex, PARP-1, Ku70/80, DNA helicases
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BLM and WRN, Rad51D, nucleotide excision repair protein
ERCC1/XPF, DNA nuclease Apollo, and the BRCT domain-
containing protein MCPH1 (3, 4, 10, 20, 35–53). To date,
much has been learned regarding the core telomere binding
components, factors that constitutively associate with the
telomeres. However, much remains unknown regarding the
factors that are recruited to the telomeres upon damage or
other signaling events, as well as the signaling cascades that
must take place on or near the telomeres. In other words, the
micro-environment—the complex regulatory network of pro-
tein-protein interactions—within which telomere homeostasis
is achieved remains to be elucidated. Signaling regulators are
often of low abundance, and their association with the targets
may be transient or weak. Although conventional proteomic
methods such as immunoprecipitation (IP) and mass spec-
trometry have been particularly informative in identifying core
interacting proteins, regulatory components may be below the
detection threshold.
We have developed a high-throughput protein-protein in-
teraction screening strategy based on the principle of the
yellow fluorescent protein (YFP)1-based protein complemen-
tation assay (PCA/bimolecular fluorescent complementation
(BiFC)) (52, 54–56). In the PCA/BiFC assay, protein-protein
interactions bring the two fragments (YFPn and YFPc) of YFP
(tagged to two separate proteins) to close proximity and allow
for their cofolding into a functional fluorescent protein (57, 58).
PCA/BiFC enables the examination of interactions in live cells,
providing spatial information about protein-protein interac-
tions. Here we report the identification of over 300 telosome/
shelterin associating proteins that mediate diverse signaling
pathways. Many of these proteins regulate post-translational
modifications including protein phosphorylation and ubiquiti-
nation. Our findings provide a high-resolution map of the
telomere interactome (19, 59, 60), and should greatly facilitate
further studies of telomere signaling.
EXPERIMENTAL PROCEDURES
Establishment of Stable Cell Lines—pDONR223 vectors encoding
SOX2, TRF1, RAP1, TIN2, and POT1 came from human ORFeome
v3.1 (Open Biosystems). Sequences encoding human TRF2 and
TPP1 were PCR amplified and cloned into pENTR/D-TOPO vector
(Invitrogen). Through Gateway recombination, the six telomere open
reading frames (ORFs) were transferred individually into either pBabe-
CMV-YFPn-DEST-neo or pBabe-CMV-DEST-YFPn-neo vectors (56).
The resulting mammalian expression constructs enable tagging of
Venus YFPn fragments at either the N- or C terminus of a protein. The
vectors were then transfected individually into Phoenix cells for ret-
rovirus production and subsequent infection of HTC75 cells. Infected
cells were selected with 300 g/ml G418 for up to 10 days to obtain
cells stably expressing YFPn-tagged bait proteins. For each bait, cells
that expressed either N- or C-terminally tagged YFPn-fusion proteins
were mixed (1:1) for subsequent screens.
Establishment of Retroviral Array Libraries—Individual Gateway re-
combination reactions (in 96-well plates) were performed for all
12,212 ORFs from hORFeome with a mixture of pCl-CMV-YFPc-
DEST-puro and pCL-CMV-DEST-YFPc-puro vectors (1:1) (56), to
generate ORFs tagged with YFPc at either the N- or C terminus. The
reaction products were subsequently used to transform DH5 and
selected by ampicilin. Plasmid extractions were then carried out in
96-well plates for each pool of bacterial transformants using PureLink
HQ 96 plasmid purification kit (Invitrogen) and Biomek FX Laboratory
Automation Work station (Beckman Coulter). 11,880 ORFs were suc-
cessfully cloned into the YFPc vectors. The YFPc-prey collections
were then transfected into Phoenix cells to generate retroviruses for
infection of bait cells. Retroviral supernatant was collected at 48 h or
72 h post-transfection, and stored in 80 °C before use. All transfec-
tion steps were done in 96-well formats using the Biomek 3000
Laboratory Automation Work station (Beckman Coulter).
High-Throughput Protein Complementation Array Screen Strategy—
Cells from each bait cell line were seeded onto 96-well plates and
infected with the arrayed YFPc-tagged prey library. At 2 days follow-
ing the infection, cells were selected with 1 g/ml of puromycin for
5–10 days. We were able to obtain 10058 SOX2, 11,685 TRF1, 11,006
TRF2, 11,724 RAP1, 11,398 TIN2, 11,385 TPP1, and 11,330 POT1 cell
lines infected by the YFPc-tagged prey library. All work was per-
formed using the Biomek3000 Laboratory Automation Work station.
Cells were then harvested for high-throughput flow cytometric anal-
ysis using the LSRII flow cytometer equipped with a HTS sampler (BD
Biosciences).
CytoArray—CytoArray is a data analysis platform custom designed
for processing the large amount of flow cytometry data from the
arrayed screen. Data processing is roughly divided into four major
steps: defining positive regions, calculating weighted positive ratios
(WPR), determining statistically significant cutoff values, and remov-
ing common contaminants (Supplemental Fig. S2).
Data from each well are plotted with green fluorescent protein
(GFP) on the x axis and phycoerythrin on the y axis. First, any samples
with 200 data points are automatically discarded. The remaining
profiles are processed plate-by-plate for each bait. All the profiles
within a plate are compiled to create a composite profile. It is as-
sumed that the majority of these flow cytometry profiles would be
negative for PCA/BiFC signals and closely resemble each other.
Therefore, the composite profile can be used as an internal control to
gate for negative versus positive regions when superimposed onto
individual profiles within the same plate (Supplemental Fig. S3). For
the composite profile, CytoArray determines the adjusted vertex and
weight center of data point distribution, and uses the y value of the
adjusted vertex and x value of the weight center to define the top and
left boundary of the positive region. Starting from here, the remaining
boundaries are defined by scanning across the distribution profile
until this positive region contains 5% of data points.
CytoArray calculates weighted positive ratios (WPR) rather than
positive percentages (PP: positive cell number/total live cell number)
to measure PCA/BiFC signals, because PP ignores signal intensity
(ratio of YFP/phycoerythrin) and does not differentiate between mar-
ginal versus significant data points. WPR increases the signal to noise
ratio and improves the sensitivity of detection (Supplemental Fig. S3).
WPR ranks all positive data points (on an arbitrary scale of 1–5)
according to their distance from the leftmost boundary of the positive
region, with the data points furthest away from that boundary as-
signed the highest value.
Next, CytoArray calculates the WPR cutoff. When the distribution
of the WPR values from all the proteins that were defined as extra-
cellular (based on cellular component annotation in Gene Ontology
database) is compared with that of the WPR values from the entire
screen for each bait, the trend is clear that the higher the WPR value,
1 The abbreviations used are: YFP, yellow fluorescence protein;
PCA, protein complementation assay; BiFC, bimolecular fluores-
cence complementation; IP, immunoprecipitation; ORF, open reading
frame; WPR, weighted positive ratios; GST, glutathione S-transferase.
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the fewer of these proteins can be found. Using these two distribution
curves, CytoArray calculates the WPR ratios between them. For ex-
ample, when the ratio is 90%, the corresponding WPR value is the
threshold cutoff with a 90% positive ratio (Supplemental Fig. S4).
Finally, common contaminants and nonspecific binding proteins are
filtered out using data from similar screens of the unrelated bait SOX2.
Coprecipitation—To validate the interactions between each bait
and prey protein pair, coprecipitation bythe glutathione S-transferase
(GST) pull-down was performed in 96-well format using 96-well filter
plates from Invitrogen. Sequences encoding telomeric proteins and
candidate prey proteins were cloned into pDEST-27 (Invitrogen) for
tagging with GST and pCl-2xFLAG for tagging with FLAG, respec-
tively. Each bait-prey pair was cotransfected into 293T cells. The
transfected cells were harvested after 2 days, and lysed with 1NETN
buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.5% Nonidet P-40, and
1 mM EDTA). The whole cell extract was then transferred to a 96-well
lysate clearing filter plate (25 m, Phenix), and centrifuged at 500  g
for 2 min (4 °C). The cleared lysate was then transferred into a 96-well
binding plate (Purelink Clarificaiton plate, Invitrogen) preloaded with
100 l/well of glutathione Sepharose 4B beads (10% slurry) (GE
Healthcare Bio-Sciences AB), and incubated for 2 h at 4 °C with
gentle agitation. The binding plate was then washed three times with
1 NETN, and the bound proteins eluted with elution buffer (50 mM
Tris-HCl, pH 8.0, 20% glycerol, 20 mM reduced glutathione), centri-
fuged at 500  g for 2 min and blotted onto polyvinylidene fluoride
membranes using the Bio-Dot apparatus (Bio-Rad). The membrane
was then probed with anti-FLAG-HRP (Sigma) or anti-GST-HRP (GE
Healthcare Bio-Sciences AB) antibodies.
RESULTS
Examining Pair-Wise Interactions Among the Six Core Te-
lomeric Proteins—To investigate protein-protein interactions
in human cells, we adopted and modified the YFP-based
PCA/BiFC method (52, 56, 58). The N-terminal fragment (res-
idues 1–155) of Venus YFP (YFPn) or the C-terminal fragment
(residues 156–239) of YFP (YFPc) were tethered to either N-
or C-terminal ends of candidate proteins and expressed in
human cells for fluorescence complementation (Figs. 1A and
1B). A flexible linker of 30 amino acids, which covers a
distance of 10 nm, was engineered to maximize comple-
mentation. Tagging protein pairs on either end with the two
YFP fragments would cover all possible interaction configu-
rations. Testing all these combinations individually, however,
would be impractical on a large scale. Here, we performed
PCA/BiFC assays using pools of cells expressing N- or C-
terminally tagged fusion proteins (Fig. 1B). For example, bait-
expressing cells were a mixture of cells that individually ex-
pressed bait proteins tagged with YFPn at either the N- or C
terminus. Likewise, each prey protein was represented by a
mixture of retroviruses encoding YFPc- fusion proteins tagged
at either the N- or C terminus. As a result, four tagging combi-
nations were simultaneously analyzed for each bait-prey pair.
Interactions among the six core telomere proteins, TRF1,
TRF2, RAP1, TPP1, TIN2, and POT1 have been studied ex-
tensively (19–21, 23–26, 61). For example, TIN2 is known to
bind TRF1, TRF2, and TPP1, whereas TPP1 and TRF2 interact
with POT1 and RAP1 respectively. In addition, TRF1 and
TRF2 may form homodimers. We first utilized the modified
PCA/BiFC strategy to analyze the pair-wise interactions within
these six proteins (Figs. 1C and 1D). As shown in Fig. 1D, we
found the pool/mixture strategy could accurately predict pair-
wise interactions among these proteins, allowing us to con-
struct the structural organization of the complex formed by
the six telomeric proteins (Fig. 1E). Importantly, tagging YFP
fragments onto either protein of the interacting pair resulted in
similar percentages of YFP-positive cells (Fig. 1D). We also
detected positive YFP signals for the TIN2-POT1 pair, sug-
gesting a close proximity of these proteins in vivo. These
findings indicate that the modified PCA/BiFC method worked
well in detecting protein-protein interactions among the core
telomeric proteins, as well as predicting their relative positions
within the complex.
It is important to note that variations in expression levels of
bait or prey proteins appeared not to affect fluorescence
complementation or the sensitivity of signal detection (Fig. 1C),
underlining the robustness of the assay. For example, POT1
exhibited fluorescence complementation comparable to others
despite having the lowest expression level among the six telo-
meric proteins, suggesting that the initial level of YFP fusion
proteins is not a major factor in this assay. It is possible that
once the correct interacting partners meet, their interaction may
help to stabilize both the prey and bait proteins, allowing for the
detection of fluorescence complementation.
Genome-wide screening of proteins that interact with the
six telomeric proteins—On the basis of our pilot studies, we
developed an arrayed screening strategy based on protein
complementation for genome-wide screening of protein-pro-
tein interactions and performed a screen for proteins that may
be involved in telomere signaling in human cells (Supple-
mental Fig. S1). We first generated individual bait HTC75 cell
lines that expressed various Venus YFPn-tagged telomeric
proteins (and a negative control bait protein SOX2). Then, a
YFPc-tagged expression prey library was constructed using
the human ORFeome library (62). This ORFeome library,
which contained 12,212 human full-length cDNAs in the
pDNOR vector, was transferred well-by-well into YFPc-
tagged retroviral destination vectors using the Gateway re-
combination system, resulting in a YFPc-tagged prey library
arrayed in 134 96-well plates (Supplemental Fig. S1). Each
reaction contained equal amount of YFPc-tagged retroviral
destination vectors for either N- or C-terminal tagging. The
success rate for cloning was estimated at 97%.
The YFPc prey library was transfected into packaging cell
lines to produce retroviruses, which were subsequently used
to infect bait cells (Supplemental Fig. S1). YFPc vectors en-
coding the six telomeric proteins were also added in this step
to serve as positive controls for the screen. The infected cells
were then selected in puromycin to enrich for prey expressing
cells, and analyzed by a high-throughput flow cytometer to
assess fluorescence complementation. A typical round of the
arrayed screen for the six telomeric proteins included about
7  12,000 individual flow cytometry measurements.
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CytoArray: An Automated Data Analysis Platform—To ana-
lyze the large amount of data generated from the screens, we
developed the CytoArray program that takes into consider-
ation various factors that affect the determination of negative
versus positive populations, including variability in sample
size and data plots. In Supplemental Fig. S2, we illustrated the
workflow for data processing using CytoArray, and the steps
taken to determine positive populations and reduce false
positives (please see Experimental Procedures for a detailed
description).
First, samples with 200 cells are discarded. The program
then assumes that the majority of samples should exhibit no
fluorescence complementation and largely resemble each
other in the overall profile. Consequently, the data files for
each plate are compiled into a single composite profile, which
is then superimposed onto individual data files within that
plate to gate for negative populations. Positive regions are
thus defined and a weighed positive ratio (WPR) is calculated
for each prey-bait pair (Supplemental Fig. S3). WPR takes into
consideration both the fluorescence signal strength and num-
ber of YFP positive cells. We reasoned that in addition to the
percentage of YFP positive cells, fluorescence intensity might
also correlate with the frequency of protein-protein interac-
tions and provide another indicator of the proximity of candi-
date interacting proteins. WPR values therefore can be used
to rank interactions revealed by PCA/BiFC.
One concern with the PCA/BiFC assay is potential false-
positives that result from nonspecific interactions or spon-
taneous cofolding of the YFP fragments (57, 58, 63). To
address this, we established a bait-specific threshold using
WPR values from all the genes and a subset of 700
extracellular proteins. The latter may be secreted or tar-
FIG. 1. PCA/BiFC reveals complex interactions among the six telomeric proteins. A, Principle of the PCA/BiFC assay. The N-terminal
fragment (residues 1–155) of Venus YFP (YFPn) and C-terminal fragment (residues 156–239) of YFP (YFPc) were tethered to the N- or
C-terminal ends of candidate proteins and expressed in human cells for fluorescence complementation. B, Schematic representation of the
retroviral expression vectors for BiFC-based screening. LTR, long terminal repeat. Puro, puromycin selection marker. Neo, neomycin selection
marker. YFPn and YFPc, N- or C-terminal fragment of YFP. C, Whole cell extracts from HTC75 cells expressing different Venus YFPn-tagged
proteins were Western blotted with anti-GFP antibodies. Fusion proteins are indicated by *. Cells expressing YFPn-tagged SOX2 were used
as a control for subsequent analysis. D, Flow cytometry analysis of the 6  6 PCA/BiFC assays of core telomeric protein pairs. YFPn-tagged
SOX2 served as a negative control. E, Structural arrangement of the subunits within the six telomeric protein complex as determined by
PCA/BiFC assays as in (D).
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geted to the membrane, therefore unlikely to interact with
telomeric proteins. This internal control helped us to deter-
mine the cutoff values for positive interactions (Supple-
mental Fig. S4 and Supplemental Fig. S5A). We then se-
lected data for the six telomere proteins from the arrayed
screen to generate a 6  6 interaction matrix to test various
thresholds (Supplemental Fig. S5B). At the 90% confidence
level, our calculated thresholds predicted most of the inter-
actions except for the TIN2-TRF2 pair (the weakest interac-
tion as determined experimentally), indicating that our sta-
tistical process for determining cutoffs is stringent in
scoring potential interacting proteins. To further exclude
possible hits because of spontaneous cofolding of the YFP
fragments, we performed a control screen using the tran-
scription factor SOX2 that is not known to play a role in
telomere biology (data not shown). The telomeric protein
screen data were further processed to remove cross-reac-
tive proteins found in the SOX2 screen, allowing us to
eliminate 30 promiscuous proteins. An additional 21 pro-
teins were discarded because they failed secondary
screens. Through CytoArray, we obtained a high-quality
data set containing 320 candidate human proteins that rep-
resent about 600 interactions (Supplemental Table S1).
The list of candidate proteins identified from the arrayed
screens includes all six telomeric proteins (Supplemental
Table S1). RAP1 and POT1 emerged respectively as the top
interactors of TRF2 and TPP1 (Fig. 2A and Supplemental
Table S1), consistent with previous findings that TRF2-RAP1
and POT1-TPP1 form stable heterodimers (20, 64, 65). Within
the human ORFeome library, a total of 14 full-length proteins
have been reported to associate with the core telomere com-
plex through 20 interactions. On the basis of these results (six
missed interactions), we calculated the false-negative rate to
be 30% (6/20). Two other known interactors, XRCC6/Ku70
(35) and PINX1 (66), were also among the best interact-
ing proteins for TRF2 and TRF1 respectively (Fig. 2A and
Supplemental Table S1).
Construction of a High-Resolution Map of the Telomere
Interactome—In addition to known interactors, the screens
revealed 300 new putative regulators of telomeres
(Supplemental Table S1). Approximately half of the identified
proteins (161) interact with a single bait protein, suggesting
FIG. 2. Identification of proteins that associate with the six telomeric proteins through our BiFC-based screens. A, Screening data for
TRF2. On the basis of CytoArray analysis, a cutoff value of 0.090 (90% confidence level) for the weighted positive ratio (WPR) was applied
(indicated by the red line). X axis, prey proteins scored in the screen. Y axis, WPR values. Arrows indicate known interacting prey proteins. B,
A heat-map of the identified interaction partners of the core telomere associated proteins. C, Enriched biological processes identified by the
screens.
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that their association with the telomeric proteins did not result
from spontaneous cofolding of YFP fragments. Some proteins
appear to interact with up to five bait proteins, which may be
partly explained by the fact that fluorescence complementa-
tion can occur between proteins that are close to each other,
without direct contact. Therefore, positive PCA/BiFC signals
may indicate close proximity rather than direct interactions.
We further examined the interaction data set by analyzing the
clustering of the identified proteins from all six baits (Fig. 2B).
In theory, bait telomeric proteins that can interact with each
other should give rise to targets that display significant over-
lap. Indeed, TRF2 interacting proteins are more closely clus-
tered with RAP1-interacting proteins (p  1.7E-05), whereas
the TIN2-, TPP1-, and POT1- interacting proteins are clus-
tered together (p  2.6E-05) (Fig. 2B), consistent with our
small-scale six-protein screen (Fig. 1D).
On the basis of our data and CytoArray analysis, we con-
structed a high-resolution map of the telomere interacting
network -Telomere Interactome (Supplemental Fig. S6). No-
tably, 80% of the interactions in our data set have not been
previously reported (28, 67). This may reflect one of the major
advantages of PCA/BiFC - its ability to capture transient,
infrequent, or low affinity interactions often missed by ap-
proaches such as IP/mass spectrometry. Using stringent cut-
off criteria, we found 11 Gene Ontology biological processes
that are statistically enriched in the network (Fig. 2C). Con-
sistent with current knowledge about telomere biology, the
top categories include telomere maintenance, chromosome
organization and biogenesis, and anti-apoptosis.
Secondary Analysis of Candidate Proteins—To confirm the
results from our screens, we carried out secondary PCA/BiFC
screens and found that the 300 proteins identified remained
positive in individual PCA/BiFC assays (Fig. 3A). Next, we
tagged the300 genes with FLAG tag and coexpressed them
individually with their respective GST-tagged bait proteins
(Fig. 3B, Supplemental Fig. S7). Binding of these proteins to
telomeric proteins was then determined by GST pull down
and dot blotting (Fig. 3C, Supplemental Fig. S8A–E). On the
basis of our analysis of the GST pulldown experiments
(Supplemental Fig. S8F and Supplemental Table S2), 72%
of the interactions could be verified by coprecipitation exper-
iments. Both weak and strong binding signals could be ob-
served. Such differences may reflect the range of interactions
between bait and prey, both in their affinity and frequency,
FIG. 3. Confirmation of protein-pro-
tein interactions identified by the
screens. A, Fluorescent microscopy im-
ages of bait-prey protein pairs tagged
with YFP fragments. HTC75 cells stably
coexpressing YFPn-tagged TRF1 and
YFPc alone (negative control), YFPc-
tagged TIN2 (positive control), YFPc-
MDH1, or YFPc-SET were visualized live
under a fluorescence microscope. Ho-
echst33342 was added to visualize the
nuclei. B, A flow chart of secondary co-
precipitation screens that were used to
confirm the identified protein-protein in-
teractions. C, Examples of coprecipita-
tion screens. Cell extracts from 293T
cells coexpressing FLAG-tagged candi-
date proteins with GST alone or GST-
tagged telomeric bait proteins were in-
cubated with GSH-agarose beads. The
proteins bound to GSH beads were then
dot-blotted and probed with anti-FLAG
antibodies.
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and lend more support to using PCA/BiFC to identify low
affinity and transient interactions. These results further dem-
onstrate the quality and reliability of our screen data. The
candidate proteins that failed to bind in the coprecipitation
assay may represent false positives, or require bridging fac-
tors or different conditions for the association to occur.
Identification of Regulatory Pathways in Telomere Signal-
ing—Telomere DNA and telomere binding proteins form the
telomere chromatin. It is therefore expected that core te-
lomere proteins will be in the vicinity of other DNA and chro-
matin associating factors. Indeed, 44 DNA binding proteins
and chromatin regulators were identified in the Telomere In-
teractome (Supplemental Table S1). Among them are several
RNA/DNA helicases including DDX19B, 21, 23, 24, and 38, as
well as several DNA and protein methyltransferases including
DNMT3A and PRMT7. An interesting pattern of association
between histone proteins and the core telomeric proteins also
emerges (Fig. 4A). In particular, the TRF2-RAP1 heterodimer
is in the vicinity of histone H2A, H4, and H1. Whether this
network represents the organization of telomere nucleosome
warrants future investigation. Finally, the six telomeric pro-
teins are known to communicate with the DNA damage repair
pathways for telomere maintenance. Our screen has added
additional players including the DNA base excision enzyme
APEX1, endonuclease FEN1, helicase RECQL4, and DNA
polymerase POLD1 (Fig. 4B).
Among the 300 proteins identified, many are regulators of
protein phosphorylation and ubiquitination (Fig. 4C and D).
These include serine/threonine kinases (Akt1, CAMK1D,
CLK3, MAP2K3, MAP4K2, MAPK12, and PAK4), and protein
phosphatase catalytic and regulatory subunits (PPM1G,
PHPT1, PTPN5, SAPS3, and PPP1R2). These proteins may
form the circuitry that controls the phosphorylation of the six
core telomeric proteins. Several RING finger or U-box con-
FIG. 4. Identification of signaling networks and regulatory components in the Telomere Interactome. A, Interaction of telomeric
proteins with histone proteins. B, DNA repair and chromatin regulators that associate with the six telomeric proteins. C, Protein kinases,
phosphatases, and their regulators are identified from the screen. D, Putative ubiquitin E3 ligases were found in the screen.
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taining proteins have also been found (Fig. 4D). These pro-
teins could function as ubiquitin E3 ligases or stability regu-
lators for telomere-associated proteins. Taken together, our
study has demonstrated that regulatory components of the
telomere interactome can be readily identified by our protein
complementation based array screen. The results presented
here should act as a catalyst for future investigations into the
multitude of regulatory pathways at work for maintaining
mammalian telomeres.
DISCUSSION
The importance of mapping protein-protein interaction
networks and elucidating regulatory components that are
integral to biological pathways cannot be overstated. Sig-
naling regulators are often of low abundance, and their
association with the targets may be transient or weak. Such
characteristics make it difficult to capture and study key
regulatory interactions, despite the wide array of tools that
have been developed over the years for protein-protein
interactions. Recent studies have demonstrated the benefit
of detecting protein-protein interactions using protein
complementation assay (PCA) systems (68). For example, a
dihydrofolate reductase-based PCA method was used to
investigate the yeast interactome, where thousands of in-
teractions were identified (69). Given that many of the yeast
genetic tools are not yet available in mammals, we decided
to employ the PCA method that utilizes split Venus YFP to
analyze the interactomes in human cells (52, 54, 56, 58).
Compared with approaches such as yeast-two-hybrid and
co-IP/mass spectrometry, it offers distinct advantages.
Pair-wise protein-protein interactions are analyzed in live
human cells, providing spatial information about protein-
protein interactions. As a nontranscription based approach,
it avoids bait self-activation and nonnuclear localization
issues that frequently plague two-hybrid methods. PCA/
BiFC is ideal for live or single cell experiments, circumvent-
ing the need for large numbers of cells and lengthy in vitro
purification steps as is the case for IP/mass spectrometry.
Most importantly, transient or weak interactions as well as
low abundance regulators that may be lost during in vitro
purification steps, can be “trapped” thanks to the cofolding
of YFP fragments. This attribute really sets it apart from other
screening methods including PCA approaches that utilize di-
hydrofolate reductase or luciferase (68, 70), and enables it to
more readily identify regulatory interactions such as those
between enzymes and their substrates. In support of this
notion, we recently used a BiFC-based screening strategy
and identified a rac-GDI protein that binds CARD9 in macro-
phages in a bacterial infection-dependent manner (71). We
anticipate that our screen strategy will make major impact in
this area and help to facilitate the process of identifying signal
dependent interactions.
The screen strategy described here detects pair-wise inter-
actions in the human proteome in a systematic manner, en-
ables the identification of regulatory interactions such as
those between enzymes and their substrates, and creates a
high-resolution map of the interactome. Here we report our
work on elucidating the interaction networks centering around
the six core telomeric proteins. Screens utilizing split GFP or
YFP have been performed previously (72, 73), however, split
GFP or YFP cofolding is much less efficient than Venus YFP
(74). In addition, previous screens were not systematic and
the resulting interactions were not further characterized, and
nonspecific interactions because of spontaneous cofolding of
the YFP fragments were not eliminated. This is the first time
an array-based high-throughput protein complementation
screen technology has been used to map interaction net-
works in live human cells. Some of the identified proteins did
not appear to localize to the telomeres in our secondary
screens. Although we cannot rule out the possibility that they
are false positives, it is possible that these proteins may be
targeted to telomeres under specific conditions. Furthermore,
telomeric proteins travel through different cellular compart-
ments following their synthesis and have been implicated in
nontelomeric activities (75, 76). Therefore, these proteins may
have novel function outside of the telomeres. Nevertheless,
the large number of newly identified and confirmed telomere
interacting proteins is a testimony to the power of the screens.
We believe that this technology will be an extremely valuable
tool to study protein networks and signaling transduction in
general, and help to relieve the bottleneck in our understand-
ing of signaling pathways in human cells.
Our current library should detect the majority of interacting
proteins within a radius of 20 nm. Differentiating between
constitutive versus induced interactions (in response to sig-
naling cues) can be easily achieved by our screening strategy.
One limitation is the need to coexpress YFP-tagged bait and
prey proteins in the same cells in order to achieve fluores-
cence complementation. YFP tags may alter the conformation
or activity of the tagged proteins and lead to false negatives.
In theory, high-affinity, direct interactions are likely to lead to
higher percentage of PCA/BiFC positive cells and stronger
fluorescence complementation. Although PCA/BiFC does ap-
pear to be more tolerant of differences in expression, high
expression levels of bait and prey may still result in false posi-
tives. Therefore, secondary screens are needed to validate the
identified interactions. The method described here may be fur-
ther improved with an inducible expression system, particularly
in cases where prolonged stable interactions between two pro-
teins might be detrimental to cells. This will help to reduce the
rate of false negatives as well. Our current PCA/BiFC array
library contains12,000 genes, approximately half of the genes
in the human genome. Expanding the array library will certainly
facilitate more complete interactome mapping.
Protein-protein interaction networks in human cells are
much more complex than we originally anticipated (77). Our
screens offer a multitude of candidates for further analysis of
their potential role in telomere biology or other pathways.
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Over 80% of the identified proteins have been validated by
secondary screens, which translates into an average of 40
binding partners for a given core telomere protein. It is unlikely
that the identified 300 proteins bind simultaneously with the
six telomeric proteins. Instead, they may form a variety of
subcomplexes and associate with the six core telomeric pro-
teins in different cellular compartments or at different times to
mediate diverse biological processes. It is equally possible
that some interactions are cell-type dependent or develop-
mentally regulated. Further studies are needed to unravel how
these processes contribute to the maintenance of telomere
homeostasis.
Consistent with the major roles of the six telomeric proteins,
the top category of biological processes scored in our screen
belongs to chromatin organization, biogenesis, and telomere
maintenance (Fig. 2C). In this category, we found many en-
zymes including helicases, methyltransferases, acetyl-trans-
ferases, kinases, and phosphatases. Whether these enzymes
associate with the telomeres constitutively or transiently re-
main to be investigated. Understanding how these enzymes
are regulated and their roles in telomere capping will be an
intriguing area of research in the near future. Another inter-
esting finding from our screen is the closeness of the TRF2-
RAP1 heterodimer, but not TIN2-TPP1-POT1 subcomplex, to
core histone subunits. This structural organization of the
telomere chromatin is consistent with the model that the
TPP1-POT1 complex is primarily involved in telomere ssDNA
protection, and thus positioned more distal from the histone-
coated dsDNA region.
It is intriguing to find apoptosis as one of the top biolog-
ical processes mediated by the Telomere Interactome. Sev-
eral proteins that are involved in stress response pathways
and mitochondria function were found in our screens. It is
possible that telomere dysfunction may trigger stress and
apoptosis signaling through these proteins. In support of
this hypothesis, it has been shown that disregulation of
telomeric proteins in mammalian cells renders these cells
sensitive to apoptosis in both p53-dependent and inde-
pendent manner (78–82). Our result suggests that the six
telomeric proteins may have a more direct role in connecting
telomere dysfunction to apoptosis.
In addition, we found a collection of E3 ligases that likely
control the stability and/or function of the six core telomeric
proteins. More than one E3 ligase may associate with a given
telomeric protein, perhaps to respond to distinct cellular sig-
naling cues or function in different cellular compartments. As
we begin to address the relationship between ubiquitination
and telomere homeostatsis, such findings offer important
clues to the participants of these biological events. We dem-
onstrate here that our arrayed screen strategy can identify
regulatory components of the telomere interactome, which
makes it an invaluable tool for signal transduction and mech-
anistic studies.
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